Related Experiment Video

Updated: Jun 27, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Applications of genomic tools to colorectal cancer therapeutics

J Todd Auman1, Howard L McLeod

  • 1UNC Institute for Pharmacogenomics and Individualized Therapy, Eshelman School of Pharmacy, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7360, USA. jtauman@email.unc.edu

Current Opinion in Molecular Therapeutics
|December 4, 2008
PubMed

Insights

Genomic tools reveal why colorectal cancer patients respond differently to chemotherapy. Gene expression profiling and mutation screening help predict treatment effectiveness, guiding personalized medicine for better outcomes.

Area of Science:

  • Oncology
  • Genomics
  • Pharmacology

Background:

  • Colorectal cancers with similar clinical and histopathological features show varied responses to chemotherapy.
  • Genomic technologies offer unbiased methods to identify DNA and RNA alterations influencing chemotherapy response variability.

Purpose of the Study:

  • To review advances in applying genomic tools for colorectal cancer therapeutics.
  • To highlight how genomic information can predict and explain chemotherapy response variability.

Main Methods:

  • Gene expression profiling to identify patient benefit from adjuvant chemotherapy.
  • Pharmacogenomic analysis to link gene expression patterns with chemotherapeutic sensitivity.
  • Genome-wide mutation screening of individual tumors to determine gene mutation profiles.

Main Results:

  • Gene expression profiling can identify colorectal cancer patients who will benefit from adjuvant chemotherapy.
  • Specific gene expression patterns are associated with sensitivity to particular chemotherapeutic agents.
  • Genome-wide mutation screening provides insights into the molecular landscape of individual colorectal tumors.

Conclusions:

  • Genomic approaches are advancing colorectal cancer therapeutics.
  • Integrating genomic data with clinical and histopathological information is crucial for improving treatment management.
  • Personalized medicine strategies in colorectal cancer can be enhanced through genomic insights.

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...